tiprankstipranks
Advertisement

IVSI - ETF AI Analysis

Compare

Top Page

IVSI

Applied Finance IVS International Large ETF (IVSI)

Rating:66Neutral
Price Target:
IVSI, the Applied Finance IVS International Large ETF, appears to be a solid but not top-tier fund, supported by strong holdings like ASML and Novartis, which bring robust financial performance, growth potential, and generally positive technical trends. These strengths are partly offset by names such as Roche and some telecom and financial holdings where valuation concerns, overbought or bearish technical signals, and leverage or cash flow issues introduce risk. The main risk factor is that several key positions show signs of potential overvaluation or weak momentum, which could increase volatility even though the overall portfolio quality is sound.
Positive Factors
Strong Overall Performance
The ETF has delivered strong year-to-date returns, showing solid momentum in its current strategy.
Leading Growth Holding
ASML Holding, the fund’s largest position, has shown very strong performance, providing a meaningful boost to the ETF.
Broad International Diversification
The fund spreads its investments across many countries including Japan, the UK, Europe, and the U.S., helping reduce the impact of weakness in any single market.
Negative Factors
Moderately High Fees
The expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.
Small Asset Base
The fund manages a relatively low amount of assets, which can make it more vulnerable to large investor inflows or outflows.
Mixed Performance Among Top Holdings
While several major positions have performed well, at least one top holding has been weak, which can drag on overall results.

IVSI vs. SPDR S&P 500 ETF (SPY)

IVSI Summary

IVSI is an actively managed ETF that invests in large, well-established companies outside the United States, aiming for long-term growth. It doesn’t track a specific index, but instead selects international large-cap stocks across many countries like Japan, the UK, and Switzerland, and sectors such as financials, health care, and consumer goods. Well-known holdings include ASML Holding and Roche. Investors might consider IVSI to diversify beyond the U.S. and gain exposure to global blue-chip companies. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, with managers doing in-depth research to pick international large-cap stocks rather than just tracking an index.
What would affect this ETF?This ETF could benefit if developed markets outside North America grow steadily, especially if demand stays strong for global health care, financial, and technology leaders like ASML, Roche, and AstraZeneca, and if a weaker U.S. dollar makes international stocks more attractive. On the other hand, it could face challenges from slower economic growth in Europe or Japan, tighter global financial conditions, changing regulations affecting banks and drug makers, or a downturn in commodity and luxury goods demand that would hurt holdings like Rio Tinto and LVMH.

IVSI Top 10 Holdings

IVSI leans heavily into developed markets outside North America, with a clear tilt toward European and Asian blue chips. ASML has been a powerful long-term engine for the fund, even if its recent trading has been choppy. Health care names like Roche and Novartis are providing steady, defensive lift, while BHP’s upswing adds a cyclical boost from materials. Financials such as Allianz and Mitsubishi UFJ are rising but more mixed, keeping the fund from feeling overly dependent on any single stock or sector, despite its global large-cap focus.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV5.49%$538.03K€560.52B115.72%
76
Outperform
Roche Holding AG3.43%$336.01K$353.49B28.54%
73
Outperform
BHP Group Ltd2.86%$280.45KAU$316.45B67.69%
68
Neutral
Novartis AG2.29%$224.61KCHF237.20B24.62%
80
Outperform
Deutsche Telekom2.12%$207.81K€135.83B-10.16%
67
Neutral
Recruit Holdings Co2.11%$206.41K¥22.04T87.22%
67
Neutral
Investor AB2.04%$199.28Kkr1.25T40.33%
77
Outperform
2.01%$196.56K
Mitsubishi UFJ Financial Group1.97%$193.02K¥42.32T54.65%
76
Outperform
Allianz1.90%$185.58K€170.64B28.18%
67
Neutral

IVSI Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
29.48
Positive
100DMA
28.77
Positive
200DMA
Market Momentum
MACD
0.15
Positive
RSI
54.78
Neutral
STOCH
44.17
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVSI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.05, equal to the 50-day MA of 29.48, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.15 indicates Positive momentum. The RSI at 54.78 is Neutral, neither overbought nor oversold. The STOCH value of 44.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IVSI.

IVSI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$9.79M0.65%
66
Neutral
$93.54M0.55%
65
Neutral
$27.34M0.55%
67
Neutral
$25.09M
66
Neutral
$22.20M0.27%
66
Neutral
$11.84M0.30%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IVSI
Applied Finance IVS International Large ETF
30.06
4.72
18.63%
QUIZ
Zacks Quality International ETF
JIDE
JPMorgan International Dynamic ETF
TACN
T. Rowe Price Active Core International Equity ETF
ENHI
iShares Enhanced International Active ETF
PQNT
Pictet AI Enhanced International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement